Class information for:
Level 1: GLUCAGON RECEPTOR//GLUCAGON RECEPTOR GENE//GLUCAGON ANTAGONIST

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
15878 618 38.2 68%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
461 15321 NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 GLUCAGON RECEPTOR Author keyword 22 51% 5% 31
2 GLUCAGON RECEPTOR GENE Author keyword 21 85% 2% 11
3 GLUCAGON ANTAGONIST Author keyword 18 89% 1% 8
4 GLUCAGON RECEPTOR ANTAGONIST Author keyword 15 68% 2% 13
5 GLUCAGON RECEPTOR ANTAGONISTS Author keyword 9 83% 1% 5
6 GLUCAGON ANTAGONISTS Author keyword 6 71% 1% 5
7 METAB DISORDERS MOL ENDOCRINOL Address 4 75% 0% 3
8 PANCREATIC ALPHA CELL Author keyword 2 38% 1% 5
9 ALPHA CELL Author keyword 2 15% 2% 14
10 GLUCAGON RECEPTOR GCGR Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 GLUCAGON RECEPTOR 22 51% 5% 31 Search GLUCAGON+RECEPTOR Search GLUCAGON+RECEPTOR
2 GLUCAGON RECEPTOR GENE 21 85% 2% 11 Search GLUCAGON+RECEPTOR+GENE Search GLUCAGON+RECEPTOR+GENE
3 GLUCAGON ANTAGONIST 18 89% 1% 8 Search GLUCAGON+ANTAGONIST Search GLUCAGON+ANTAGONIST
4 GLUCAGON RECEPTOR ANTAGONIST 15 68% 2% 13 Search GLUCAGON+RECEPTOR+ANTAGONIST Search GLUCAGON+RECEPTOR+ANTAGONIST
5 GLUCAGON RECEPTOR ANTAGONISTS 9 83% 1% 5 Search GLUCAGON+RECEPTOR+ANTAGONISTS Search GLUCAGON+RECEPTOR+ANTAGONISTS
6 GLUCAGON ANTAGONISTS 6 71% 1% 5 Search GLUCAGON+ANTAGONISTS Search GLUCAGON+ANTAGONISTS
7 PANCREATIC ALPHA CELL 2 38% 1% 5 Search PANCREATIC+ALPHA+CELL Search PANCREATIC+ALPHA+CELL
8 ALPHA CELL 2 15% 2% 14 Search ALPHA+CELL Search ALPHA+CELL
9 GLUCAGON RECEPTOR GCGR 2 67% 0% 2 Search GLUCAGON+RECEPTOR+GCGR Search GLUCAGON+RECEPTOR+GCGR
10 PANCREATIC ALPHA CELLS 1 31% 1% 4 Search PANCREATIC+ALPHA+CELLS Search PANCREATIC+ALPHA+CELLS

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ALPHA CELL HYPERPLASIA 25 73% 3% 19
2 ENDOGENOUS GLUCAGON 19 80% 2% 12
3 HYPERGLUCAGONEMIA 19 36% 7% 43
4 ALKYLIDENE HYDRAZIDES 15 82% 1% 9
5 SWITCH OFF HYPOTHESIS 14 55% 3% 17
6 REPLACEMENT ANALOGS 7 53% 2% 10
7 PANCREATIC ALPHA CELLS 6 27% 3% 19
8 INTACT ISLETS 6 32% 2% 15
9 A CELLS 6 23% 4% 22
10 CONFORMATIONAL CONSIDERATIONS 6 100% 1% 4

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes 2012 41 87 45%
ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion 2014 4 77 47%
Pancreatic alpha-Cell Hyperplasia: Facts and Myths 2014 4 48 46%
Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? 2011 36 57 47%
Glucagon antagonism as a potential therapeutic target in type 2 diabetes 2011 26 69 54%
The role of dysregulated glucagon secretion in type 2 diabetes 2011 41 57 39%
Lack of glucagon receptor signaling and its implications beyond glucose homeostasis 2015 1 66 41%
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes 2009 37 71 54%
A survey of small molecule glucagon receptor antagonists from recent patents (2006-2010) 2011 7 35 77%
Physiology of the pancreatic alpha-ce glucose secretion: role in glucose homeostasis and diabetes 2008 73 147 30%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 METAB DISORDERS MOL ENDOCRINOL 4 75% 0.5% 3
2 METAB DISORDER MOL ENDOCRINOL 1 100% 0.3% 2
3 UNITE CHIM BIOL NUTR 1 100% 0.3% 2
4 CARCINOID NEUROENDOCRINE TUMOR 1 30% 0.5% 3
5 CARDIOVASC METAB ENDOCRINE DIS CHEM 1 40% 0.3% 2
6 COMBINATORIAL CHEM TECHNOL 1 40% 0.3% 2
7 PACIFIC NW DIABET 1 33% 0.3% 2
8 ST S AD TAT RECOGNIT 1 33% 0.3% 2
9 ENDOCRINE DISCOVERY 1 17% 0.6% 4
10 GUANGDONG PLANT OURCES LIFE SCI 1 50% 0.2% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000169091 PANCREATIC DIABETES//INSULIN LIKE IMMUNOREACTIVITY//CALCIFYING PANCREATITIS
2 0.0000117335 GLUCAGON LIKE PEPTIDE 1//EXENATIDE//LIRAGLUTIDE
3 0.0000103267 SECRETIN RECEPTOR//SECRETIN//SECRETIN RECEPTORS
4 0.0000086505 UNITE ENDOCRINOL METAB//PANCREATIC BETA CELL//INSULIN RELEASE
5 0.0000077779 C PEPTICLE//CLIN PHYSIOL METAB UNIT//HENRY WELLCOME S EGRATED CELL SIGNALLING
6 0.0000071607 INSULIN DEGRADING ENZYME//NEPRILYSIN//INSULYSIN
7 0.0000069607 IMMUNOHISTOCHEMISTRY OF BONE//FRESH FROZEN SECTION//ADULT BONE
8 0.0000068975 GLUCONEOGENESIS//GLYCOGENOLYSIS//ENDOGENOUS GLUCOSE PRODUCTION
9 0.0000065984 HEPATIC AMINO NITROGEN CONVERSION//UREA SYNTHESIS//AMMONIOGENESIS
10 0.0000063924 HYPOGLYCAEMIA UNAWARENESS//COUNTERREGULATION//HYPOGLYCAEMIA